India · Delayed Price · Currency is INR Shilpa Medicare Statistics
Total Valuation
Shilpa Medicare has a market cap or net worth of INR 107.71 billion. The enterprise value is 113.85 billion.
| Market Cap | 107.71B |
| Enterprise Value | 113.85B |
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Shilpa Medicare has 195.58 million shares outstanding. The number of shares has increased by 0.38% in one year.
| Current Share Class | 195.58M |
| Shares Outstanding | 195.58M |
| Shares Change (YoY) | +0.38% |
| Shares Change (QoQ) | +3.56% |
| Owned by Insiders (%) | 48.51% |
| Owned by Institutions (%) | 16.20% |
| Float | 95.74M |
Valuation Ratios
The trailing PE ratio is 44.27 and the forward PE ratio is 40.05. Shilpa Medicare's PEG ratio is 1.50.
| PE Ratio | 44.27 |
| Forward PE | 40.05 |
| PS Ratio | 7.00 |
| PB Ratio | 4.16 |
| P/TBV Ratio | 5.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 31.48 |
| PEG Ratio | 1.50 |
Enterprise Valuation
| EV / Earnings | 46.79 |
| EV / Sales | 7.40 |
| EV / EBITDA | 25.20 |
| EV / EBIT | 34.28 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.25.
| Current Ratio | 1.31 |
| Quick Ratio | 0.67 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 1.52 |
| Debt / FCF | -23.19 |
| Interest Coverage | 5.36 |
Financial Efficiency
Return on equity (ROE) is 9.82% and return on invested capital (ROIC) is 8.35%.
| Return on Equity (ROE) | 9.82% |
| Return on Assets (ROA) | 5.61% |
| Return on Invested Capital (ROIC) | 8.35% |
| Return on Capital Employed (ROCE) | 11.02% |
| Weighted Average Cost of Capital (WACC) | 5.59% |
| Revenue Per Employee | 15.42M |
| Profits Per Employee | 2.44M |
| Employee Count | 998 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 1.29 |
Taxes
In the past 12 months, Shilpa Medicare has paid 519.90 million in taxes.
| Income Tax | 519.90M |
| Effective Tax Rate | 17.60% |
Stock Price Statistics
The stock price has increased by +19.74% in the last 52 weeks. The beta is 0.22, so Shilpa Medicare's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | +19.74% |
| 50-Day Moving Average | 470.34 |
| 200-Day Moving Average | 378.20 |
| Relative Strength Index (RSI) | 61.02 |
| Average Volume (20 Days) | 74,798 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shilpa Medicare had revenue of INR 15.39 billion and earned 2.43 billion in profits. Earnings per share was 12.44.
| Revenue | 15.39B |
| Gross Profit | 10.78B |
| Operating Income | 3.15B |
| Pretax Income | 2.95B |
| Net Income | 2.43B |
| EBITDA | 4.35B |
| EBIT | 3.15B |
| Earnings Per Share (EPS) | 12.44 |
Balance Sheet
The company has 451.80 million in cash and 6.60 billion in debt, with a net cash position of -6.15 billion or -31.43 per share.
| Cash & Cash Equivalents | 451.80M |
| Total Debt | 6.60B |
| Net Cash | -6.15B |
| Net Cash Per Share | -31.43 |
| Equity (Book Value) | 25.91B |
| Book Value Per Share | 132.46 |
| Working Capital | 2.62B |
Cash Flow
In the last 12 months, operating cash flow was 3.42 billion and capital expenditures -3.71 billion, giving a free cash flow of -284.50 million.
| Operating Cash Flow | 3.42B |
| Capital Expenditures | -3.71B |
| Depreciation & Amortization | 1.20B |
| Net Borrowing | 710.00M |
| Free Cash Flow | -284.50M |
| FCF Per Share | -1.45 |
Margins
Gross margin is 70.08%, with operating and profit margins of 20.47% and 15.81%.
| Gross Margin | 70.08% |
| Operating Margin | 20.47% |
| Pretax Margin | 19.19% |
| Profit Margin | 15.81% |
| EBITDA Margin | 28.25% |
| EBIT Margin | 20.47% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 0.11%.
| Dividend Per Share | 0.60 |
| Dividend Yield | 0.11% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 4.02% |
| Buyback Yield | -0.38% |
| Shareholder Yield | -0.27% |
| Earnings Yield | 2.26% |
| FCF Yield | -0.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Shilpa Medicare is 530.50, which is -3.67% lower than the current price. The consensus rating is "Buy".
| Price Target | 530.50 |
| Price Target Difference | -3.67% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on October 3, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Oct 3, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |